Biological
Regulatory T cells
Regulatory T cells is a biological therapy with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
6
100%
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
6(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(2)
Other(3)
Detailed Status
unknown3
Completed2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 16 (100.0%)
Trials by Status
completed233%
active_not_recruiting117%
unknown350%
Recent Activity
1 active trials
Showing 5 of 6
active_not_recruitingphase_1
Cell Therapy for Immunomodulation in Kidney Transplantation
NCT03867617
completedphase_1
Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis
NCT04691232
completedphase_1
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD
NCT01911039
unknownphase_1
A Safety and Tolerability Study of GB301
NCT03865017
unknownphase_1
Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis
NCT02704338
Clinical Trials (6)
Showing 6 of 6 trials
NCT03867617Phase 1
Cell Therapy for Immunomodulation in Kidney Transplantation
NCT04691232Phase 1
Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis
NCT01911039Phase 1
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD
NCT03865017Phase 1
A Safety and Tolerability Study of GB301
NCT02704338Phase 1
Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis
NCT01624077Phase 1
Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6